During the past decade, Win Retina conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Win Retina" #1 sponsor was "Allergan" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Clearside Biomedical, Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Xbrane Biopharma AB" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Win Retina" #1 collaborator was "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Win Retina" are "Macular Degeneration" (4 trials), "Diabetic Macular Edema" (3 trials), "Diabetic Retinopathy" (1 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Win Retina" in a lesser frequency.

Most popular intervention types in "Win Retina" are "Drug" (8 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (4 trials), "Sham Procedure" (3 trials), "Abicipar pegol" (2 trials), "RO7200220" (2 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Win Retina" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Win Retina". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Win Retina, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Win Retina, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".